Viridian Therapeutics
VRDN
#3908
Rank
โ‚ฌ2.61 B
Marketcap
27,45ย โ‚ฌ
Share price
-0.22%
Change (1 day)
48.49%
Change (1 year)

Viridian Therapeutics (VRDN) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ18.57 Million

According to Viridian Therapeutics's latest financial reports the company's total debt is โ‚ฌ18.57 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Viridian Therapeutics - Total debt on balance sheet (from 2013 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ20.27 M6.47%
2023-12-31โ‚ฌ19.04 M288.43%
2022-12-31โ‚ฌ4.9 M967.55%
2021-12-31โ‚ฌ0.45 M24.12%
2020-12-31โ‚ฌ0.36 M-95.01%
2019-12-31โ‚ฌ7.41 M-17.65%
2018-12-31โ‚ฌ9 M8.86%
2017-12-31โ‚ฌ8.26 M732.36%
2016-12-31โ‚ฌ0.99 M-1.69%
2015-12-31โ‚ฌ1.01 M1436.39%
2014-12-31โ‚ฌ0.06 M-99.66%
2013-12-31โ‚ฌ19.26 M12.64%
2012-12-31โ‚ฌ17.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ2.83 M-84.73%๐Ÿ‡บ๐Ÿ‡ธ USA